Stockreport

How Investors May Respond To Cencora (COR) Deepening Its Rare Disease Services Through Curant Collaboration [Yahoo! Finance]

Cencora, Inc.  (COR) 
Last cencora, inc. earnings: 4/30 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.coresite.com/investor-overview
PDF capabilities with Curant Rare's specialty pharmacy and patient-engagement services to support rare disease therapies. This partnership is designed to give rare disease [Read more]